athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “market perform” rating reiterated by equities researchers at William Blair in a research note issued on Friday.

Several other equities research analysts also recently commented on the company. Cantor Fitzgerald reaffirmed a “buy” rating and set a $118.00 target price (down from $135.00) on shares of athenahealth in a report on Thursday, April 27th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $160.00 target price on shares of athenahealth in a report on Tuesday, April 4th. Argus began coverage on athenahealth in a report on Friday, July 7th. They set a “hold” rating for the company. Citigroup Inc. reissued a “buy” rating and set a $163.00 price target (up from $128.00) on shares of athenahealth in a research report on Monday, June 5th. Finally, J P Morgan Chase & Co set a $136.00 price target on athenahealth and gave the company a “hold” rating in a research report on Wednesday. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and twelve have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $141.00.

Shares of athenahealth (ATHN) traded up 7.30% on Friday, hitting $154.30. The stock had a trading volume of 972,063 shares. The firm has a market cap of $6.15 billion, a P/E ratio of 303.74 and a beta of 1.79. athenahealth has a 12-month low of $90.11 and a 12-month high of $158.66. The company’s 50-day moving average price is $141.51 and its 200 day moving average price is $122.62.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. athenahealth had a return on equity of 5.93% and a net margin of 1.84%. The company’s revenue was up 15.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.34 earnings per share. On average, equities research analysts forecast that athenahealth will post $1.86 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “athenahealth, Inc. (NASDAQ:ATHN) Given Market Perform Rating at William Blair” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/21/athenahealth-inc-nasdaqathn-given-market-perform-rating-at-william-blair.html.

In other athenahealth news, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $109.48, for a total value of $32,844.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. Insiders sold a total of 25,683 shares of company stock valued at $3,329,871 in the last quarter. Corporate insiders own 3.20% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Janus Capital Management LLC boosted its position in shares of athenahealth by 18.1% in the fourth quarter. Janus Capital Management LLC now owns 5,738,978 shares of the health services provider’s stock worth $603,596,000 after buying an additional 878,970 shares during the last quarter. Lord Abbett & CO. LLC bought a new position in shares of athenahealth during the fourth quarter worth about $73,215,000. First Trust Advisors LP bought a new position in shares of athenahealth during the fourth quarter worth about $71,884,000. Finally, Morgan Stanley boosted its position in shares of athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after buying an additional 397,837 shares during the last quarter.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.